Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADH1A | P07327 | Alcohol dehydrogenase 1A (EC 1.1.1.1) (Alcohol dehydrogenase subunit alpha) | EnzymesFDA approved drug targetsMetabolic proteins | Exposure to noxious substances harmful effect | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.53 | |||
| AUXI | O75061 | Auxilin (EC 3.1.3.-) (DnaJ homolog subfamily C member 6) | Disease related genesEnzymesHuman disease related genes | Parkinson disease | Adhesion and uptake mediationFusion and delivery mediation | 3 | 0.53 | |||
| CCR2 | P41597 | C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192) | CD markersG-protein coupled receptorsHuman disease related genes | 7 | Alzheimer diseaseArterial occlusive diseaseChronic kidney disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| CD3E | P07766 | T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e) | CD markersDisease related genesFDA approved drug targets | 1 | Breast cancerMelanomaMycosis fungoides | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| COF2 | Q9Y281 | Cofilin-2 (Cofilin, muscle isoform) | Disease related genesHuman disease related genesPlasma proteins | Nemaline myopathy | Fusion and delivery mediation | 3 | 0.53 | |||
| CTNB1 | P35222 | Catenin beta-1 (Beta-catenin) | Cancer-related genesDisease related genesHuman disease related genes | Intellectual disabilityColon cancerDesmoid tumour | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | |||
| CXCR3 | P49682 | C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD antigen CD183) | CD markersG-protein coupled receptorsPredicted membrane proteins | 7 | Hepatic fibrosis/cirrhosisPostoperative inflammationPsoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.53 | ||
| EPCAM | P16422 | Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) | Cancer-related genesCD markersDisease related genes | 1 | Hereditary nonpolyposis colorectal cancerBladder cancerBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| ESAM | Q96AP7 | Endothelial cell-selective adhesion molecule | Plasma proteinsPredicted membrane proteins | 1 | Intellectual disability | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 3 | 0.53 | ||
| FPR3 | P25089 | N-formyl peptide receptor 3 (FMLP-related receptor II) (FMLP-R-II) (Formyl peptide receptor-like 2) | 7 | Alzheimer disease | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 3 | 0.53 |